AsianScientist (Aug. 23, 2016) – Chinese genome sequencing company BGI has chosen QIMR Berghofer Medical Research Institute in Queensland, Australia as its research and development and commercialization headquarters for the Asia Pacific region.
BGI is one of the largest genome sequencing companies in the world, with its global headquarters based in Shenzhen, China. The company has 47 laboratories worldwide.
Professor Jian Wang, president and co-founder of BGI, said the excellent facilities and research programs at QIMR Berghofer Medical Research Institute, along with Queensland’s existing life science institutions, industries and networks made it an obvious choice for BGI’s Asia Pacific headquarters.
According to QIMR Berghofer’s director and CEO Professor Frank Gannon, BGI will occupy office and laboratory space at their premises and operate independently of the institute.
Source: QIMR Berghofer.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.